🚀 Exciting Collaboration Announcement! 🚀 We are thrilled to announce a groundbreaking partnership between Ymmunobio and EVIIVE to advance the future of cancer diagnostics! Together, we are developing an innovative liquid biopsy technology using extracellular vesicles (EVs), enhancing precision in disease detection and monitoring Our joint efforts will leverage Ymmunobio 's cutting-edge biotechnological expertise and EVIIVE's advanced diagnostic platforms to create a revolutionary tool in the fight against cancer. Ymmunobio and EVIIVE are pioneering advances in diagnostics and oncology, working towards a future where healthcare is more personalized, precise, and effective for all patients. Stay tuned for more updates as we work towards a brighter, healthier future! #CancerResearch #Biotech #LiquidBiopsy #InnovationInHealthcare #Ymmunobio #EVIIVE #CancerDetection #HealthcareInnovation #CollaborationForCure https://lnkd.in/dBK-vrvM
EVIIVE
Biotechnologieforschung
Unleash the full potential of liquid biopsies for the earliest disease prevention and personalized treatment guidance
Info
Revolutionizing healthcare through advanced liquid biopsies: Uncovering novel biomarkers for early diagnosis, precise prognosis, and continuous monitoring of host responses
- Website
-
https://www.eviive.ch/
Externer Link zu EVIIVE
- Branche
- Biotechnologieforschung
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Zürich
- Art
- Privatunternehmen
- Gegründet
- 2022
- Spezialgebiete
- Cancer, Infectious Disease, Aging, Precision medicine, Liquid biopsies, Machine learning, Biomarkers, Diagnosis, Prognosis, extracellular vesicles und exosome
Orte
-
Primär
Winterthurerstrasse 190
Zürich, 8057, CH
Beschäftigte von EVIIVE
Updates
-
EVIIVE hat dies direkt geteilt
Exciting news for EVIIVE (Richard Chahwan), 1st place in the Health & Nutrition vertical in the prestigious >>venture>> Startup Competition! Proud to receive positive and inspiring feedback from the advisory panel to shape the next-generation biomarker discovery for precision medicine. University of Zurich UZH Innovation Hub UZH IncubatorLab BioEntrepreneurship & Innovation (BEI) program Therapy Development Accelerator - UZH Michio Painter, PhD Liliane Brunner Halbach Venture Kick Venturelab BRIDGE Programme Gebert Rüf Stiftung W.A. De Vigier Stiftung Innosuisse
🌟 Announcing the 2024 >>venture>> Winners! 🌟 After months of rigorous selection, insightful pitch training, and invaluable mentoring, we are thrilled to share that our winners have finally come to the end of their journey with us and we're proud to announce the final rankings for the 2024 edition, starting with the winners of the Health & Nutrition vertical: 🥇 First place: EVIIVE 🥈 Second place: Procavea Biotech 🥉 Third place: Cultivated Biosciences Congratulations to all our winners! Your hard work and dedication have paid off. #StartupCompetition #Health #Nutrition #VentureStartupCompetition
-
EVIIVE hat dies direkt geteilt
Stoked to present EVIIVE this afternoon at the esteemed W.A. De Vigier Stiftung award ceremony! Follow us live from 17:30 CET!
👉 LATER TODAY: Which of the Top 10 nominees will win a coveted W.A. de Vigier Award? 🎬 Watch the #award 🏆 ceremony live at http://devigier.ch! The livestream begins at 17.30. apheros , Ascento , EVIIVE , Grensol Group , Neology Hydrogen , Optiml , PEROVSKIA SOLAR AG , Tandem Therapeutics , Tethys Robotics , Treeless Pack, Startupticker.ch #StartupCompetition
-
EVIIVE hat dies direkt geteilt
When the most recognized competitions call for the most promising startups - our ventures take the stage: Congratulations to 10 Venturelab alumni that won the 2024 >>venture>> Startup Competition!!! https://lnkd.in/daeQZa_B Starring: Borobotics GmbH - innovative geothermal drilling https://lnkd.in/e4xPTYmB Brian – The AI Teaching Assistant https://lnkd.in/exPVqsUQ Cultivated Biosciences: Production of dairy fats by microbial fermentation. https://lnkd.in/efP2Twy5 EVIIVE: Next-generation liquid biopsy solution https://lnkd.in/eEUgWMGy Optiml: Net Zero real estate investment and renovation planning https://lnkd.in/eBrvpY_g qCella AG: (re)shape product heating https://lnkd.in/ePKhYftf Planeto: Digital design of climate-neutral district heating networks https://lnkd.in/e2sWNvk9 Procavea Biotech: Innovative molecular delivery solutions for medicine https://lnkd.in/e7jEkry6 Rapidata: Powering AI with rapid and scalable human data processing. https://lnkd.in/ebpC6n9T RTDT Laboratories AG: The digital doctor for wind turbines https://lnkd.in/efADzrFk #SwissStartups
-
Honored to be the winners of the 2024 cohort of >>venture>> Startup Competition! Another great effort from our team!
We are thrilled to announce the 2024 >>venture>> winners! 🎉 It's our absolute pleasure to introduce the top 18 most innovative early-stage startups that emerged from a pool of 329 submissions, showcasing Switzerland's most promising talents. With so many game-changing ideas, this was no easy feat for our jurors, but our winners have proved to be la crème de la crème! Join us in congratulating CLIMADA Technologies, CrowdTransfer, MC² Finance, Cultivated Biosciences, EVIIVE, Procavea Biotech, Optiml, Planeto, Rapidata, Borobotics GmbH, qCella, RTDT Laboratories AG, Bergmobil, Brian – The AI Teaching Assistant, WEPOT, ALIEN Limited, InvestConservation®, Malaica 👏 For more details about our winners, head over to our website: https://lnkd.in/daeQZa_B
-
EVIIVE hat dies direkt geteilt
Nucleate Switzerland had an incredible opportunity to showcase our talented sciencepreneurs at the #SwissBiotechDay organized by the Swiss Biotech Association last week! 🚀 A HUGE thank you to the organizers for making this event possible. We would like to deeply thank Michael Altorfer for giving us this opportunity, and to Maximilien Murone, and Christin Tauscher for helping us organize our session. We're grateful for everyone who joined our panel and supported our teams SYDRA (Alexander Dakhovnik), inSEIT (David Roura Padrosa, PhD), DropGen (Claudius Dietsche and Maximilian Breitfeld), Inkocell Therapeutics (Angela Madurga Alonso and Mathieu Girardin), EVIIVE (Kevin Yim, PhD and Richard Chahwan), and IMPLANZ (Nicolas Gasser). Your encouragement means the world to us! We are specially grateful to our amazing jury: Katharina Kreymborg (Curie.Bio), Zoë Johnson (M:M Bio), and Antoine Boulanger (Forbion) for their valuable feedback and guidance. 👏 In addition to our pitching session, a special shoutout to CSL Behring for hosting a mentoring booth, and a big thanks to Marco Cavallari for orchestrating it all. Your dedication to nurturing talent is inspiring! 🌱 Finally, thank you to our leadership team Dr. Rishika A., Sara Svanberg, and Anamaria Buzoianu for moderating and organizing the session and representing us at the Swiss Biotech Day. Events like these not only spotlight our early stage life science entrepreneurs but also help them integrate into the vibrant Swiss biotech ecosystem. 🌍 If you missed the action or want to see more, mark your calendars for our Demo Day on May 30th at the Novartis Pavillon. It's an event you won't want to miss! 🗓️. You can register here: https://lu.ma/y5usnvnf #Nucleate #SwissBiotechDay #DemoDay #Innovation #BiotechCommunity
-
EVIIVE hat dies direkt geteilt
Connecting global hubs of life science: at the Swiss Biotech Day 2024 in Basel, the Swiss National Startup Team made their premiere, kicking off their roadshow to Boston. Discover: https://lnkd.in/eguUFqWu Starring the Venture Leaders Biotech 2024: David Pejoski | Adoram Therapeutics: The allosteric way to best-in-class small molecule therapies https://lnkd.in/gs4S4wF7 Maria Van Dongen | Allegria Therapeutics: Therapeutics that modulate mast cell activity https://lnkd.in/ggr7uNAE Kevin Ho Wai Yim | EVIIVE: Next-generation liquid biopsy solution https://lnkd.in/egNS7d5P David Roura Padrosa, inSEIT: Enzyme immobilization for green industrial production https://lnkd.in/g8QTJQyy Bryan Christopher Porcello, KYLYS AESTHETICS SA: Revolutionizing Skin Filling Science https://lnkd.in/gRzSgnss David Klein Cerrejon | OBaris: a painless alternative to injectable drugs. https://lnkd.in/ghYzaCGq Arin Ghasparian | Shape Biopharmaceuticals Inc.: Redefining Immunotherapy https://lnkd.in/gJ-RM3hP Gabriel Liguori, TissueLabs: The platform for creating organs and tissues in the lab. https://lnkd.in/gCBd_FJ9 Ian Metcalfe | Well Science AG: Natural immune support against allergic rhinitis https://lnkd.in/gAKUZCkq Peter Schiemann | Ymmunobio : First in class oncology drugs for unmet need https://lnkd.in/g6HQbjW5 The Venture Leaders Biotech roadshow will present Switzerland’s most innovative biotech startups to international investors and industry leaders at the global hub of life sciences in the Greater Boston Area. The Venture Leaders Biotech will introduce themselves and their startups at a kick-off event at the Swiss Biotech Day in Basel on April 22, 2024: https://lnkd.in/gBn4ZUd Venture Leaders Biotech is organized by Venturelab in partnership with Swissnex in Boston and New York and supported by Debiopharm, EPFL, ETH Zürich, Hansjörg Wyss, Kellerhals Carrard Startup & VC Desk, Novartis, Swiss Biotech Association, and VISCHER. Follow the entrepreneurs and the Venture Leaders Biotech roadshow on social media using the #VLeadersBiotech or on https://lnkd.in/g3MX32CE. #SwissStartups #VLeadersBiotech
-
Thank you for the precious support and recognition from W.A. De Vigier Stiftung!
Our Top 15 had in-depth talks with the jury last week. Selecting 10 startups to move forward in the running for a W.A. #devigier Award is not an easy task - we were once again so impressed with these young, inspiring CEOs 🤩 ! Stay tuned and save the date for the award ceremony on June 19, live at www.devigier.ch apheros Ascento BTRY EVIIVE Foldcast KWiiD MYNERVA Neology Hydrogen Neurosoft Bioelectronics Optiml PEROVSKIA SOLAR AG Tandem Therapeutics Tethys Robotics Treeless Pack
-
EVIIVE hat dies direkt geteilt
Kevin Yim, PhD presenting again, back to back, at the Swiss Biotech Day 2024 showcasing EVIIVE's know-how and future tech applications. Thanks Venturelab for the opportunity. #swissbiotechday #eviive #liquidbiopsy #precisionmedicine
-
EVIIVE hat dies direkt geteilt
Kevin Yim, PhD presenting EVIIVE's technology at the Swiss Biotech Day 2024 in Basel, CH. Thanks Nucleate Switzerland for the opportunity. #swissbiotechday #eviive #liquidbiopsy #innovation #precisionmedicine